[1] 胡治勇, 崔龙, 董晓颖, 等. 糖尿病患者骨质疏松评估、危险因素及相关机制的研究进展[J]. 重庆医学, 2020, 49(4):660-664. doi:  10.3969/j.issn.1671-8348.2020.04.033
[2]

ALAM, JAFARIRM, DEHPOURAR. Diabetes mellitus and osteoporosis correlation: challenges and hopes[J]. Curr Diabetes Rev,2020,16(9):984-1001. doi:  10.2174/1573399816666200324152517
[3] 吕茵, 周围, 何文娜, 等. 2型糖尿病合并骨质疏松影响因素研究[J]. 新医学, 2020, 51(1):33-36. doi:  10.3969/j.issn.0253-9802.2020.01.007
[4] 黄燕霞, 梅思. 糖尿病性骨质疏松的研究进展[J]. 临床与病理杂志, 2020, 40(1):182-187. doi:  10.3978/j.issn.2095-6959.2020.01.031
[5] 倪利华. 糖尿病性骨质疏松症的研究进展[J]. 临床与病理杂志, 2020, 40(7):1897-1901. doi:  10.3978/j.issn.2095-6959.2020.07.043
[6]

PASCHOU S Α, DEDE A D, ANAGNOSTIS P G, et al. Type 2 diabetes and osteoporosis: a guide to optimal management[J]. J ClinEndocrinolMetab,2017,102(10):3621-3634.
[7] 李弘磊, 杨涛, 范红旗. 2型糖尿病合并骨质疏松的相关因素分析[J]. 中国医药, 2015, 10(5):644-648. doi:  10.3760/cma.j.issn.1673-4777.2015.05.012
[8]

POIANA C. Osteoporosis and fracture risk in patients with type 2 diabetes mellitus[J]. ActaEndo (Buc),2019,15(2):231-236. doi:  10.4183/aeb.2019.231
[9] 易云平, 张思伟, 潘虹. 老年2型糖尿病骨质疏松相关因素分析[J]. 中国骨质疏松杂志, 2017, 23(1):59-61,111. doi:  10.3969/j.issn.1006-7108.2017.01.013
[10]

ARDAWI M S M, AKHBAR D H, ALSHAIKH A, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes[J]. Bone,2013,56(2):355-362. doi:  10.1016/j.bone.2013.06.029
[11] 韩栋, 王奔, 卢晓栋, 等. 中老年2型糖尿病患者发生骨质疏松的影响因素[J]. 中国慢性病预防与控制, 2020, 28(2):149-151. doi:  10.16386/j.cjpccd.issn.1004-6194.2020.02.016
[12]

XU H, WANG Z D, LI X R, et al. Osteoporosis and osteopenia among patients with type 2 diabetes aged ≥50: role of sex and clinical characteristics[J]. J Clin Densitom,2020,23(1):29-36. doi:  10.1016/j.jocd.2019.04.004
[13] 郑倩莲, 徐家林. 唑来膦酸注射液在糖尿病骨质疏松患者中的实施意义[J]. 糖尿病新世界, 2020, 23(16):78-80. doi:  10.16658/j.cnki.1672-4062.2020.16.078
[14]

SCHWARTZ A V. Efficacy of osteoporosis therapies in diabetic patients[J]. Calcif Tissue Int,2017,100(2):165-173. doi:  10.1007/s00223-016-0177-8
[15]

SEALAND R, RAZAVI C, ADLER R A. Diabetes mellitus and osteoporosis[J]. CurrDiabetes Rep,2013,13(3):411-418.
[16] 赵蕾, 王立, 鲁梅花, 等. 唑来膦酸与阿仑膦酸钠治疗绝经后骨质疏松症的效果和安全性比较[J]. 中国综合临床, 2017, 33(12):1134-1137. doi:  10.3760/cma.j.issn.1008-6315.2017.12.019
[17]

KURRA S, FINK D A, SIRIS E S. Osteoporosis-associated fracture and diabetes[J]. EndocrinolMetabClinN Am,2014,43(1):233-243.
[18] 马远征, 王以朋, 刘强, 等. 中国老年骨质疏松症诊疗指南(2018)[J]. 中国骨质疏松杂志, 2018, 24(12):1541-1567.
[19] 孙军平, 徐向阳, 吕刚. 糖尿病性骨质疏松症的治疗进展[J]. 医学综述, 2017, 23(13):2634-2638. doi:  10.3969/j.issn.1006-2084.2017.13.030